Sale!

MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MYOZ2 gene associated with familial hypertrophic cardiomyopathy type 16. This comprehensive genetic analysis utilizes next-generation sequencing technology to detect specific genetic variations that can lead to abnormal heart muscle thickening and cardiovascular complications. The test is particularly valuable for individuals with family history of cardiomyopathy, unexplained cardiac symptoms, or those seeking proactive cardiac health management. Results provide crucial information for early intervention, personalized treatment planning, and family risk assessment. The test costs $500 USD and delivers results within 3-4 weeks, offering significant savings from the regular $700 price.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Heart Conditions

The MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing method specifically targets mutations in the MYOZ2 gene, which plays a critical role in maintaining the structural integrity and function of cardiac muscle cells. Familial hypertrophic cardiomyopathy type 16 is an inherited condition characterized by abnormal thickening of the heart muscle, potentially leading to serious cardiovascular complications if left undetected.

What This Test Measures and Detects

This comprehensive genetic analysis utilizes next-generation sequencing (NGS) technology to examine the complete coding region of the MYOZ2 gene. The test specifically identifies:

  • Pathogenic variants in the MYOZ2 gene associated with familial hypertrophic cardiomyopathy
  • Single nucleotide polymorphisms (SNPs) affecting cardiac muscle function
  • Insertion and deletion mutations impacting sarcomere structure
  • Genetic markers linked to progressive heart muscle thickening
  • Inheritance patterns for family risk assessment

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Unexplained chest pain or discomfort during physical activity
  • Family history of sudden cardiac death or cardiomyopathy
  • Abnormal heart rhythms or palpitations without clear cause
  • Shortness of breath during routine activities
  • Dizziness or fainting episodes
  • Abnormal echocardiogram results showing heart muscle thickening
  • Relatives diagnosed with hypertrophic cardiomyopathy

Significant Benefits of Genetic Testing

Undergoing the MYOZ2 genetic test provides numerous advantages:

  • Early Detection: Identify genetic predisposition before symptoms develop
  • Personalized Treatment: Tailor medical interventions based on genetic profile
  • Family Planning: Make informed decisions about genetic inheritance risks
  • Proactive Monitoring: Implement appropriate cardiac surveillance protocols
  • Lifestyle Guidance: Adjust physical activities and lifestyle choices accordingly
  • Peace of Mind: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Your genetic test results will fall into one of several categories:

  • Positive Result: Indicates the presence of a known pathogenic MYOZ2 mutation. This confirms genetic predisposition to familial hypertrophic cardiomyopathy type 16 and warrants comprehensive cardiac evaluation and monitoring.
  • Negative Result: No known pathogenic mutations detected. While reassuring, this doesn’t completely rule out other genetic or non-genetic causes of cardiomyopathy.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unknown clinical impact. These findings require careful interpretation and may need family studies for clarification.

Test Pricing and Availability

Test Feature Details
Test Name MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We have established testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and cardiovascular specialists ensures comprehensive pre-test counseling and post-test support.

Take Control of Your Cardiac Health Today

Don’t wait for symptoms to develop before addressing potential genetic cardiac risks. The MYOZ2 Gene Cardiomyopathy test provides definitive genetic information that can guide your healthcare decisions and potentially save lives through early intervention. Our team of genetic specialists and cardiologists are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take the first step toward understanding your genetic cardiac health with confidence and clarity.